ArticleOncotarget2015

ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs).

Pramudita R Prasetyanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.